Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1000
+0.0100 (11.11%)
Jun 9, 2026, 5:19 PM EST
Rapid Dose Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is March - February.
Millions CAD. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 |
Net Income | -4.37 | -5.4 | -4.31 | -3.81 | -8.49 | -1.81 |
Depreciation & Amortization | 0.46 | 0.24 | 0.62 | 0.63 | 0.77 | 0.68 |
Asset Writedown & Restructuring Costs | - | - | - | - | 4.08 | - |
Stock-Based Compensation | 0.65 | 1.42 | 0.16 | 0.71 | 1.7 | - |
Provision & Write-off of Bad Debts | - | - | -0.01 | 0.02 | - | - |
Other Operating Activities | 1.51 | 1.08 | 0.75 | 0.13 | 0.15 | 0.07 |
Change in Accounts Receivable | -0.07 | -0.08 | -0.07 | 0.02 | 0.2 | -0.14 |
Change in Inventory | -0.07 | -0.11 | 0.01 | 0.08 | -0.04 | -0.19 |
Change in Accounts Payable | 1.01 | 1.64 | 0.62 | 1.31 | -0.47 | 0.45 |
Change in Unearned Revenue | - | - | -0.01 | -0.01 | -0.88 | -0.63 |
Change in Other Net Operating Assets | 0.02 | 0.07 | -0.06 | 0.06 | -0.02 | -0.05 |
Operating Cash Flow | -0.86 | -1.15 | -2.29 | -0.86 | -3 | -1.62 |
Capital Expenditures | -0.01 | -0.01 | - | - | -0.04 | -0.01 |
Sale of Property, Plant & Equipment | - | - | - | - | 0 | - |
Cash Acquisitions | - | - | - | - | 1.89 | - |
Other Investing Activities | -2.55 | - | - | - | - | - |
Investing Cash Flow | -2.55 | -0.01 | - | - | 1.85 | -0.01 |
Short-Term Debt Issued | - | - | 0.43 | 0.81 | 0.13 | 1.1 |
Long-Term Debt Issued | - | - | 1.83 | 0.2 | - | - |
Total Debt Issued | 3.13 | - | 2.26 | 1.01 | 0.13 | 1.1 |
Short-Term Debt Repaid | - | -0.25 | -0.7 | - | - | - |
Long-Term Debt Repaid | - | -0.13 | -0.34 | -0.31 | -0.29 | -0.26 |
Total Debt Repaid | -0.04 | -0.38 | -1.04 | -0.31 | -0.29 | -0.26 |
Net Debt Issued (Repaid) | 3.09 | -0.38 | 1.22 | 0.7 | -0.16 | 0.84 |
Issuance of Common Stock | 0.4 | 1.39 | 1.3 | 0.15 | 1.28 | 0.9 |
Other Financing Activities | - | - | -0.09 | - | - | -0.09 |
Financing Cash Flow | 3.49 | 1.01 | 2.43 | 0.86 | 1.13 | 1.65 |
Foreign Exchange Rate Adjustments | - | - | - | 0 | -0.02 | 0.05 |
Net Cash Flow | 0.07 | -0.14 | 0.13 | -0.01 | -0.04 | 0.07 |
Free Cash Flow | -0.87 | -1.15 | -2.29 | -0.86 | -3.04 | -1.63 |
Free Cash Flow Margin | -31.33% | -55.27% | -224.91% | -120.27% | -173.52% | -216.20% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.01 | -0.03 | -0.02 |
Cash Interest Paid | - | - | - | 0.08 | 0.07 | 0.14 |
Levered Free Cash Flow | -0.09 | -0.21 | -1.89 | 0.55 | -1.55 | -1.11 |
Unlevered Free Cash Flow | 0.72 | 0.56 | -1.48 | 0.72 | -1.47 | -1.02 |
Change in Working Capital | 0.89 | 1.52 | 0.49 | 1.46 | -1.21 | -0.56 |